XLRN

Acceleron Pharma Inc.
XLRN

Overview Fund Activity
Delisted

XLRN was delisted on the 19th of November, 2021.

Back to rankings

149 hedge funds and large institutions have $1.47B invested in Acceleron Pharma Inc. in 2017 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 55 increasing their positions, 35 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
149
Holders Change
+21
Holders Change %
+16.41%
% of All Funds
3.72%
Holding in Top 10
6
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+100%
% of All Funds
0.15%
New
32
Increased
55
Reduced
35
Closed
10
Calls
$2.48M
Puts
$11.5M
Net Calls
-$9.06M
Net Calls Change
-$3.61M

Top Buyers

1
FCM
1
Farallon Capital Management
California
$35.9M
2
PA
2
Perceptive Advisors
New York
$60.3M
3
Citigroup
3
Citigroup
New York
$32M
4
DM
4
Deerfield Management
New York
$23M
5
Deutsche Bank
5
Deutsche Bank
Germany
$34.6M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$139M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$118M
3
GPP
3
Great Point Partners
Connecticut
$6.34M
4
Millennium Management
4
Millennium Management
New York
$13.4M
5
Westfield Capital Management
5
Westfield Capital Management
Massachusetts
$57.5M
Name Holding Trade Value Shares
Change 		Shares
Change %
Millennium Management
26
Millennium Management
New York
$13.4M -$6.87M -184,174 -34%
GTC
27
Ghost Tree Capital
New York
$13.1M +$9.7M +260,000 +289%
First Manhattan
28
First Manhattan
New York
$12.2M -$93.3K -2,500 -0.8%
UBS AM
29
UBS AM
Illinois
$12.1M +$176K +4,718 +1%
Geode Capital Management
30
Geode Capital Management
Massachusetts
$12M +$1.07M +28,689 +10%
Artisan Partners
31
Artisan Partners
Wisconsin
$11.9M +$11.9M +319,871 New
FCMI
32
Foresite Capital Management III
California
$10.4M +$9.66M +258,867 +1,302%
Axa
33
Axa
France
$10M -$2.03M -54,463 -17%
FCMI
34
Foresite Capital Management II
California
$9.13M +$9.13M +244,756 New
Citadel Advisors
35
Citadel Advisors
Florida
$8.86M +$6.83M +182,963 +335%
GIM
36
Granahan Investment Management
Massachusetts
$8.1M +$1.07M +28,694 +15%
Hudson Bay Capital Management
37
Hudson Bay Capital Management
Connecticut
$7.93M +$3.45M +92,500 +77%
GPP
38
Great Point Partners
Connecticut
$6.34M -$12.1M -323,500 -66%
Bank of New York Mellon
39
Bank of New York Mellon
New York
$6.18M +$1.01M +27,084 +20%
BBA
40
Baker Bros. Advisors
New York
$6.12M +$5.04M +135,135 +470%
UBS Group
41
UBS Group
Switzerland
$6M +$2.04M +54,780 +52%
MWNA
42
Marshall Wace North America
New York
$5.91M +$5.07M +136,966 +600%
Charles Schwab
43
Charles Schwab
California
$5.9M +$527K +14,110 +10%
IBT
44
International Biotechnology Trust
United Kingdom
$5.75M -$898K -24,010 -14%
SSA
45
Schonfeld Strategic Advisors
New York
$5.38M +$5.38M +144,017 New
LCM
46
Laurion Capital Management
New York
$5.32M +$5.32M +142,630 New
MIM
47
Monashee Investment Management
Massachusetts
$4.67M – – –
CS
48
Candriam SCA
Luxembourg
$4.4M +$373K +10,000 +9%
New York State Common Retirement Fund
49
New York State Common Retirement Fund
New York
$4.08M +$2.8M +75,046 +219%
Principal Financial Group
50
Principal Financial Group
Iowa
$3.92M +$29.4K +788 +0.8%
1
2
3 4 5